NASDAQ:CLPT ClearPoint Neuro (CLPT) Stock Price, News & Analysis $9.07 -0.57 (-5.91%) Closing price 04:00 PM EasternExtended Trading$9.11 +0.04 (+0.43%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About ClearPoint Neuro Stock (NASDAQ:CLPT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get ClearPoint Neuro alerts:Sign Up Key Stats Today's Range$9.00▼$9.6050-Day Range$9.07▼$16.9652-Week Range$8.27▼$28.10Volume965,013 shsAverage Volume796,425 shsMarket Capitalization$276.64 millionP/E RatioN/ADividend YieldN/APrice Target$25.67Consensus RatingHold Company Overview ClearPoint Neuro, Inc. is a medical technology company that develops and commercializes image-guided systems for minimally invasive neurosurgical procedures. Its platform is designed to help physicians plan, navigate and monitor procedures within the brain, using magnetic resonance imaging (MRI) to support accurate placement of instruments and therapeutic agents. The company’s product portfolio includes the ClearPoint Neuro navigation system and related disposable components, including cranial access and guidance products. These technologies are used in procedures such as biopsies, laser ablation, deep brain stimulation lead placement and the delivery of drugs or gene therapies directly to targeted areas of the brain. ClearPoint Neuro also provides planning, software and procedural support services for hospitals, research institutions and pharmaceutical or biotechnology companies developing neurological treatments. The company was formerly known as MRI Interventions, Inc. and adopted the ClearPoint Neuro name in 2020. Its technologies are used primarily in the United States, with international activities supported through commercial and research relationships. ClearPoint Neuro is headquartered in Solana Beach, California, and serves the neurosurgical, pharmaceutical and biotechnology markets.AI Generated. May Contain Errors. Read More ClearPoint Neuro Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks35th Percentile Overall ScoreCLPT MarketRank™: 1.744761161 of 5 starsClearPoint Neuro scored higher than 35% of companies evaluated by MarketBeat, and ranked 717th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingClearPoint Neuro has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialClearPoint Neuro has a consensus price target of $25.67, representing about 183.0% upside from its current price of $9.07.Amount of Analyst CoverageClearPoint Neuro has only been the subject of 1 research reports in the past 90 days.Read more about ClearPoint Neuro's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for ClearPoint Neuro are expected to grow in the coming year, from ($1.22) to ($1.16) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ClearPoint Neuro is -7.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ClearPoint Neuro is -7.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClearPoint Neuro has a P/B Ratio of 9.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about ClearPoint Neuro's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.78% of the float of ClearPoint Neuro has been sold short.Short Interest Ratio / Days to CoverClearPoint Neuro has a short interest ratio ("days to cover") of 6.01.Change versus previous monthShort interest in ClearPoint Neuro has recently increased by 9.99%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldClearPoint Neuro does not currently pay a dividend.Dividend GrowthClearPoint Neuro does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.36 News SentimentClearPoint Neuro has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for ClearPoint Neuro this week, compared to 2 articles on an average week.Search Interest1 people have searched for CLPT on MarketBeat in the last 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, ClearPoint Neuro insiders have not sold or bought any company stock.Percentage Held by Insiders6.94% of the stock of ClearPoint Neuro is held by insiders.Percentage Held by Institutions30.08% of the stock of ClearPoint Neuro is held by institutions.Read more about ClearPoint Neuro's insider trading history. Receive CLPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLPT Stock News HeadlinesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTOctober 15 at 10:00 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTOctober 13 at 5:49 PM | globenewswire.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.October 16 at 1:00 AM | Weiss Ratings (Ad)INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTOctober 8, 2026 | prnewswire.comCLPT Investors with $100,000 in Losses Have Opportunity to Join ClearPoint Neuro, Inc. Fraud Investigation with SBS LawOctober 7, 2026 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTOctober 6, 2026 | globenewswire.comHead to Head Analysis: IceCure Medical (NASDAQ:ICCM) vs. ClearPoint Neuro (NASDAQ:CLPT)October 5, 2026 | americanbankingnews.comClearPoint Neuro: My Speculative Buy Didn't Pan Out, Moving To HoldOctober 1, 2026 | seekingalpha.comSee More Headlines CLPT Stock Analysis - Frequently Asked Questions How have CLPT shares performed this year? ClearPoint Neuro's stock was trading at $13.68 on January 1st, 2026. Since then, CLPT shares have decreased by 33.7% and is now trading at $9.07. How were ClearPoint Neuro's earnings last quarter? ClearPoint Neuro, Inc. (NASDAQ:CLPT) released its quarterly earnings data on Monday, August, 3rd. The company reported ($0.38) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by $0.09. The company earned $10.88 million during the quarter, compared to the consensus estimate of $12.73 million. ClearPoint Neuro had a negative net margin of 81.76% and a negative trailing twelve-month return on equity of 188.09%. Read the conference call transcript. Who are ClearPoint Neuro's major shareholders? ClearPoint Neuro's top institutional investors include Lodestone Wealth Management LLC (0.04%). Insiders that own company stock include Joseph Burnett, Timothy T Richards, Lynnette C Fallon and Matthew B Klein. View institutional ownership trends. How do I buy shares of ClearPoint Neuro? Shares of CLPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of ClearPoint Neuro own? Based on aggregate information from My MarketBeat watchlists, some other companies that ClearPoint Neuro investors own include Palantir Technologies (PLTR), Block (XYZ), NVIDIA (NVDA), TransMedics Group (TMDX), Trade Desk (TTD), Stem (STEM) and Super Micro Computer (SMCI). Company Calendar Last Earnings8/03/2026Today10/16/2026Next Earnings (Estimated)10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 2 weeks, CLPT's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:CLPT CIK1285550 Webwww.clearpointneuro.com Phone(949) 900-6833Fax949-900-6834Employees172Year Founded1998Price Target and Rating Average Price Target for ClearPoint Neuro$25.67 High Price Target$30.00 Low Price Target$22.00 Potential Upside/Downside+183.0%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($1.18) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$25.54 million Net Margins-81.76% Pretax Margin-81.80% Return on Equity-188.09% Return on Assets-40.88% Debt Debt-to-Equity Ratio4.66 Current Ratio4.74 Quick Ratio3.89 Sales & Book Value Annual Sales$36.97 million Price / Sales7.48 Cash FlowN/A Price / Cash FlowN/A Book Value$0.99 per share Price / Book9.16Miscellaneous Outstanding Shares30,500,000Free Float28,387,000Market Cap$276.64 million OptionableOptionable Beta1.29 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:CLPT) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
